Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Vir Biotech plans to start mid-to-late stage study of COVID-19 antibody this month

Monoclonal antibody has neutralised SARS-CoV-2 virus in vitro

- PMLiVE

Russia becomes first country to approve a COVID-19 vaccine

Vaccine approved after less than two months of human testing

- PMLiVE

US pays $1.5bn for 100 million doses of Moderna’s COVID-19 vaccine

Latest deal is part of Operation Warp Speed

- PMLiVE

Ex-J&J exec Denice Torres joins bluebird bio’s board

Torres brings over 25 years of executive management experience to the role

- PMLiVE

Novavax plans to meet US COVID-19 vaccine demand in 2021

Company plans to produce two billion doses if vaccine proves effective

- PMLiVE

Sinovac begins late-stage COVID-19 vaccine trial

Late-stage trial will recruit up to 1,620 participants in Indonesia

- PMLiVE

Seres’ microbiome-based therapy hits the mark in phase 3

Drug reduced C.difficile infection recurrence

Combating Coronavirus Through Reversing Diabetes

The Diabetes Reversal Company has developed a pioneering programme based on sustainable weight loss, evidence-based lifestyle change and one-to-one clinical support to reduce and reverse the effects of Type 2...

Onyx Health

- PMLiVE

Delivering safe and effective clinical trials during the COVID-19 pandemic

By Jorg Taubel

- PMLiVE

Eli Lilly, Innovent showcase Tyvyt data in first-line NSCLC

Detailed phase 3 results presented at the virtual World Conference on Lung Cancer

- PMLiVE

Biogen’s highly-anticipated Alzheimer’s drug wins FDA fast-track

Drug could become first treatment to reduce clinical decline in Alzheimer's

Roche Basel Switzerland

Roche scores FDA approval for SMA drug risdiplam, now named Evrysdi

Drug poised to challenge rivals Spinraza and Zolgensma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links